, The Stock Exchange of Thailand With respect to the financial statements for the year ended 31 December 2019, as submitted by the Company, which has been audited by the external auditor, considered by

Page 1 of 4 No. RJH – SET 3/2020 24 February 2020 Subject : Management’s Discussion and Analysis for the 4th Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital

26 February 2020 Subject : Management Discussion and Analysis for 2019 To : Director and the President, The stock Exchange of Thailand Yggdrazil Group Public Company Limited (“Company”) would like to

Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the year 2017. The MD&A would enable the investors to better

. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public

Page 1 of 4 No. RJH – SET 8/2019 13 May 2019 Subject : Management’s Discussion and Analysis for the First Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public

2nd quarter ended 30 June 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 2nd quarter ended 30 June 2019, as submitted by the Company

Page 1 of 4 No. RJH – SET 7/2018 11 May 2018 Subject : Management’s Discussion and Analysis for the 1st quarter of 2018 ending March 31, 2018 To : The President The Stock Exchange of Thailand

หนังสือแสดงการรับทราบความผิด 14 August 2018 Subject : Management Discussion and Analysis of the second quarter 2018 ended 30 June 2018 Attn. : Director and Manager The Stock Exchange of Thailand

Page 1 of 4 No. RJH – SET 16/2019 11 November 2019 Subject : Management’s Discussion and Analysis for the 3rd Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital